PharVision Advisers »

Mednax shares owned by PharVision Advisers

Quarter-by-quarter ownership of Mednax (MD) shares owned by PharVision Advisers from 13F filings

Historical chart of PharVision Advisers investment in Mednax

Tip: Access up to 7 years of quarterly data

All positions including Mednax held by PharVision Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mednax by PharVision Advisers

Quarter filed Position value Share count Share price at filing
2024-12-31 $245k 19k 13.12

More positions owned by PharVision Advisers

Wayfair Cl A (W)
ExlService Holdings (EXLS)
Up Fintech Hldg Sponsored Ads (TIGR)
Array Technologies Com Shs (ARRY)
Sprouts Fmrs Mkt (SFM)
Corporacion Amer Arpts S A (CAAP)
Vertiv Holdings Com Cl A (VRT)
Zevra Therapeutics Com New (ZVRA)
Bowhead Specialty Hldgs Com Shs (BOW)
Lexinfintech Hldgs Adr (LX)
Euronet Worldwide (EEFT)
Rigel Pharmaceuticals (RIGL)
Masimo Corporation (MASI)
LSB Industries (LXU)
Bright Horizons Fam Sol In D (BFAM)

View all positions for PharVision Advisers

Top funds holding Mednax

BlackRock
Vanguard Group
Victory Capital Management
State Street Corporation
Dimensional Fund Advisors
American Century Companies
FMR
Geode Capital Management
D. E. Shaw & Co
Nuveen
Charles Schwab Investment Management
Robeco Investment Management
Renaissance Technologies
Qube Research & Technologies
Northern Trust

View all funds holding Mednax